London, England-based Imperial College London’s Wendy Atkin, PhD, and colleagues conducted a retrospective cohort analysis on the effects of colonoscopy surveillance on colorectal cancer incidence. Researchers found 11,944 patients had intermediate-risk adenomas between 1990 and 2010. Approximately 58 percent of those patients had a surveillance visit, while 42 percent underwent only a baseline visit. Researchers compared the groups after a median eight-year follow-up.
Here’s what they found:
1. After researchers followed up, 210 cancers were diagnosed.
2. One surveillance visit was associated with a 43 percent reduction in risk for CRC, two visits were associated with a 49 percent reduction.
3. The incidence of CRC among the hazard ratios subset decreased after one surveillance exam.
4. The incidence of CRC was 247 for high-risk patients and 93 for low-risk patients.
Researchers concluded, “For patients with high-risk features, a single follow-up exam had a profound effect. One surveillance exam reduced CRC risk by 48 percent, and two exams by 55 percent. The greatest benefit was seen in patients with poor-quality exams and high-risk lesions, of which one surveillance exam reduced the risk by 56 percent and two reduced risk by 66 percent over no surveillance.”
More articles on gastroenterology:
Last patient completes visit for Immuron’s phase II NASH study — 4 insights
Demonstrating their value — How the Digestive Health Physicians Association is fighting for independent gastroenterology
GI leader to know: Dr. James Singer of Arizona Digestive Health
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
